190 related articles for article (PubMed ID: 34597997)
1. Long non-coding RNA ASMTL-AS1 deteriorates the oncogenicity of osteosarcoma by decoying microRNA-342-3p and consequently raising ADAM9 expression.
Hou C; Sun F; Sun M
Biochem Biophys Res Commun; 2021 Nov; 579():89-96. PubMed ID: 34597997
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract][Full Text] [Related]
3. The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1).
Mou Y; Sun Q
Bioengineered; 2022 Jan; 13(1):746-758. PubMed ID: 34859735
[TBL] [Abstract][Full Text] [Related]
4. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.
Dai JH; Huang WZ; Li C; Deng J; Lin SJ; Luo J
Cell Cycle; 2019 Oct; 18(20):2727-2741. PubMed ID: 31432728
[No Abstract] [Full Text] [Related]
5. Long noncoding RNA
Li S; Liu F; Pei Y; Wang W; Zheng K; Zhang X
Aging (Albany NY); 2019 Sep; 11(18):7678-7693. PubMed ID: 31525734
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
[TBL] [Abstract][Full Text] [Related]
7. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer.
Sun J; Li X; Yu E; Liu J; Sun L; He Q; Lu Q
Diagn Pathol; 2021 May; 16(1):45. PubMed ID: 34006305
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA RHPN1-AS1 exerts pro-oncogenic actions in osteosarcoma by functioning as a molecular sponge of miR-506 to positively regulate SNAI2 expression.
Wang L; Liu Y
Cell Cycle; 2020 Jun; 19(12):1517-1529. PubMed ID: 32401134
[TBL] [Abstract][Full Text] [Related]
9. A1BG-AS1 promotes the biological functions of osteosarcoma cells via regulating the microRNA-148a-3p/USP22 axis and stabilizing the expression of SIRT1 through deubiquitinase function.
Han X; Yin M; Gong C; Zhang C; Zhu G; Hu M; Tan K; Jiang L; Wang G; Li L
Expert Opin Ther Targets; 2023; 27(10):1017-1029. PubMed ID: 37747800
[TBL] [Abstract][Full Text] [Related]
10. LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma.
Luo XF; Wu XJ; Wei X; Wang AG; Wang SH; Wang JL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8751-8760. PubMed ID: 31696461
[TBL] [Abstract][Full Text] [Related]
11. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA
Li S; Zheng K; Pei Y; Wang W; Zhang X
Aging (Albany NY); 2019 Dec; 11(23):11609-11623. PubMed ID: 31801112
[TBL] [Abstract][Full Text] [Related]
13. LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.
Li C; Wang P; Du J; Chen J; Liu W; Ye K
IUBMB Life; 2021 Jan; 73(1):286-298. PubMed ID: 33314669
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.
Si Z; Yu L; Jing H; Wu L; Wang X
J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
[TBL] [Abstract][Full Text] [Related]
17. Exosome-transferred long non-coding RNA ASMTL-AS1 contributes to malignant phenotypes in residual hepatocellular carcinoma after insufficient radiofrequency ablation.
Ma D; Gao X; Liu Z; Lu X; Ju H; Zhang N
Cell Prolif; 2020 Sep; 53(9):e12795. PubMed ID: 32722884
[TBL] [Abstract][Full Text] [Related]
18. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis.
Cui H; Zhao J
J Cell Biochem; 2020 Mar; 121(3):2284-2293. PubMed ID: 31680323
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ADIRF antisense RNA 1 upregulates insulin receptor substrate 1 to decrease the aggressiveness of osteosarcoma by sponging microRNA-761.
Xu L; Tan Y; Xu F; Zhang Y
Bioengineered; 2022 Feb; 13(2):2028-2043. PubMed ID: 35030964
[TBL] [Abstract][Full Text] [Related]
20. LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway.
Tong CJ; Deng QC; Ou DJ; Long X; Liu H; Huang K
Aging (Albany NY); 2021 May; 13(16):20116-20130. PubMed ID: 34048366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
